Rita Lai-Han Hui

17PUBLICATIONS
12CO-AUTHORS
Regenerative medicine (incl. stem cells)NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Social epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 30, 2026
Effectiveness of switching from reference adalimumab to biosimilar adalimumab-atto in patients with chronic non-infectious uveitis.

|Mar 27, 2026
Effectiveness and safety of trastuzumab-anns compared to reference trastuzumab among patients with HER2-positive breast cancer: A non-inferiority study.

Patrick Shin, Fang Niu, Dara D Nguyen

|Oct 10, 2025
Clinical and out-of-pocket cost outcomes after switching to biosimilar adalimumab-atto in patients with rheumatoid arthritis.

Antony T-H Lin, Fang Niu, Rita L Hui

|Apr 01, 2025
Perceptions of patients with inflammatory bowel diseases on switching from reference product adalimumab to biosimilar adalimumab-atto.

Catherine Pham, Deana Bitar, Fang Niu

|Feb 06, 2025
Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system.

Joan C Lo, Malini Chandra, Mehreen M Khan

|Jan 03, 2025
Safety of Low-Dose Quetiapine for Insomnia in Older Adults.

Rita L Hui, Ashley L Lee, Eric A Lee

Pageof 3

Frequent Collaborators

6 joint publications

Fang Niu

5 joint publications

Thomas Delate

4 joint publications

Catherine Pham

2 joint publications

Kim Ngoc Le